MX2012000576A - Agentes anti-influenza. - Google Patents

Agentes anti-influenza.

Info

Publication number
MX2012000576A
MX2012000576A MX2012000576A MX2012000576A MX2012000576A MX 2012000576 A MX2012000576 A MX 2012000576A MX 2012000576 A MX2012000576 A MX 2012000576A MX 2012000576 A MX2012000576 A MX 2012000576A MX 2012000576 A MX2012000576 A MX 2012000576A
Authority
MX
Mexico
Prior art keywords
influenza agents
influenza
agents
sialidases
compounds
Prior art date
Application number
MX2012000576A
Other languages
English (en)
Spanish (es)
Inventor
Mark Von Itzstein
Jeffrey Clifford Dyason
Robin Thomson
Santosh Rudrawar
Mauro Pascolutti
Original Assignee
Univ Griffith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009903329A external-priority patent/AU2009903329A0/en
Application filed by Univ Griffith filed Critical Univ Griffith
Publication of MX2012000576A publication Critical patent/MX2012000576A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41921,2,3-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX2012000576A 2009-07-16 2010-07-16 Agentes anti-influenza. MX2012000576A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009903329A AU2009903329A0 (en) 2009-07-16 Anti-influenza agents
PCT/AU2010/000905 WO2011006208A1 (en) 2009-07-16 2010-07-16 Anti -influenza agents

Publications (1)

Publication Number Publication Date
MX2012000576A true MX2012000576A (es) 2012-07-20

Family

ID=43448806

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012000576A MX2012000576A (es) 2009-07-16 2010-07-16 Agentes anti-influenza.

Country Status (11)

Country Link
US (1) US20120202877A1 (enExample)
EP (1) EP2454248A4 (enExample)
JP (1) JP2012532894A (enExample)
CN (1) CN102612514B (enExample)
AU (1) AU2010273184B2 (enExample)
CA (1) CA2768081A1 (enExample)
IL (1) IL217523A0 (enExample)
MX (1) MX2012000576A (enExample)
RU (1) RU2012105073A (enExample)
SG (1) SG177633A1 (enExample)
WO (1) WO2011006208A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9788539B2 (en) 2011-05-17 2017-10-17 Velico Medical, Inc. Platelet protection solution having beta-galactosidase and sialidase inhibitors
WO2014055988A1 (en) 2012-10-05 2014-04-10 Velico Medical, Inc. Platelet additive solution having a beta-galactosidase inhibitor
JP6453050B2 (ja) * 2013-11-15 2019-01-16 国立大学法人富山大学 2−デオキシ−2,3−ジデヒドロシアル酸誘導体およびその製造法
JP6786095B2 (ja) * 2016-07-27 2020-11-18 国立研究開発法人理化学研究所 シアル酸類縁体
WO2018213933A1 (en) 2017-05-25 2018-11-29 The Governors Of The University Of Alberta Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase
CN114423754A (zh) * 2019-07-30 2022-04-29 格里菲斯大学 抗病毒剂和其用途
US12116382B2 (en) 2022-11-28 2024-10-15 Hongene Biotech Corporation Functionalized N-acetylgalactosamine analogs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
JPH11279168A (ja) * 1996-07-22 1999-10-12 Sankyo Co Ltd ノイラミン酸誘導体
US5948816A (en) * 1996-09-10 1999-09-07 Daikin Industries, Ltd. 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
AUPR001000A0 (en) * 2000-09-08 2000-10-05 Biota Scientific Management Pty Ltd Novel chemical compounds and their use
US7045535B2 (en) * 2001-03-08 2006-05-16 Biocryst Pharmaceuticals, Inc. Compounds useful for inhibiting paramyxovirus neuraminidase

Also Published As

Publication number Publication date
AU2010273184A1 (en) 2012-03-01
IL217523A0 (en) 2012-02-29
AU2010273184B2 (en) 2015-07-09
SG177633A1 (en) 2012-02-28
CA2768081A1 (en) 2011-01-20
US20120202877A1 (en) 2012-08-09
WO2011006208A1 (en) 2011-01-20
RU2012105073A (ru) 2013-08-27
CN102612514A (zh) 2012-07-25
CN102612514B (zh) 2016-01-13
EP2454248A1 (en) 2012-05-23
JP2012532894A (ja) 2012-12-20
EP2454248A4 (en) 2013-04-03

Similar Documents

Publication Publication Date Title
PH12017502300A1 (en) Pesticidal compositions and processes related thereto
JOP20180102A1 (ar) مركب صيدلاني
PH12013500360B1 (en) Pesticidal compositions
PH12017501298A1 (en) Pesticidal compositions and processes related thereto
PH12013502686A1 (en) Pesticidal compositions and processes related thereto
PH12014500930A1 (en) Pesticidal compositions and processes related thereto
PH12014500910A1 (en) Pesticidal compositions and processes related thereto
PH12015501392A1 (en) Pesticidal compositions and processes related thereto
MX2011011763A (es) Composiciones plaguicidas.
MX382899B (es) Composiciones y métodos que comprenden variantes de proteasa termolisina.
PH12015501393A1 (en) Pesticidal compositions and processes related thereto
CO7111287A2 (es) Composiciones plaguicidas y procesos relacionados
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
PH12015501394A1 (en) Pesticidal compositions and processes related thereto
MX2012000576A (es) Agentes anti-influenza.
MX2011007101A (es) Composiciones de hidrolizados proteicos que tienen capacidad mejorada para liberar colecistocinina (cck).
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
ES2572001T3 (es) Derivado de bisfurano antivírico como inhibidor de la proteasa del VIH e intermedios del mismo
BRPI0919048B8 (pt) Composições pesticidas
UY32439A (es) Mezclas pesticidas
MY165088A (en) Pharmaceutical compositions comprising alisporivir
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
NZ717192A (en) Anti-inflammatory tripeptides
MX2012008253A (es) Uso farmaceutico de compuestos multiciclicos como agentes anti-sindrome de inmunodeficiencia adquirida.
RU2009122188A (ru) Средство, повышающее противоопухолевый эффект метотрексата

Legal Events

Date Code Title Description
FA Abandonment or withdrawal